Search clinical trials for: triamcinolone acetonide aqueous nasal spray (Nasacort® AQ)

Total 6 results

Apotex Inc.

Completed

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Mayo Clinic
Aventis Pharmaceuticals

Completed

Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays

Rhinitis | Otitis Media With Effusion | Otitis Media, Serous | Negative Middle Ear Pressure | Otitis Media, Secretory

United States
Sanofi

Completed

Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis

Rhinitis, Allergic, Perennial and/or Seasonal

United States
Stanford University

Completed

The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation

Nasal Obstruction

United States
Sunovion

Completed

A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler

Allergic Rhinitis (AR)

United Kingdom
Sunovion

Completed

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

Perennial Allergic Rhinitis

United States

3

Subscribe